Virtual BELNUC’21 Symposium

Virtual BELNUC Symposium 2021

Online one-day symposium on May 8th, 2021


A virtual one-day symposium on May 8th 2021

Replacing the Antwerp ’21 in-person symposium, we are happy to announce a one-day virtual-only meeting on May 8th 2021.

REGISTRATION IS CLOSED (Deadline: May 05, 2021)

Thank you for attending!

YNC Award Winners

After counting the (close!) votes, BELNUC is proud to announce the winners of this year’s Young Nuclearist Challenge:

1st prize (€300): dr. J. Gebruers (117 points)

2nd prize (€200): dr. A. Deleu (110 points)

3rd prize (€100): dr. N. Ahmadi (109 points)

Congratulations to the winners and thank you to all authors who submitted their work to BELNUC!

Trophy hunt

The winner of the exhibition trophy hunt will be announced in the June newsletter!


You can download the final program here.

Bone SPECT/CT: Joint forces in joint disease 09:00 – 09:30 Knives out: Operative techniques in foot and ankle surgery S. Desmyter
09:30 – 10:00 Seeing is believing: SPECT/CT in foot and ankle pain G. Gnanasegaran
10:00 – 10:30 Extinguishing the fire: radiosynoviorthesis in joint synovitis K. Liepe
Young Nuclearist Challenge 11:00 – 11:10 Solitary intense striatal hypermetabolism in candida encephalitis. D. Van Weehaeghe
11:10 – 11:20 An Unexpected Culprit of SVC Syndrome N. Ahmadi
11:20 – 11:30 MEN-1 and hibernoma: a serendipitous association? L. Guillaume
11:30 – 11:40 Painful ophthalmoplegia in a patient with a history of marginal zone lymphoma. C. Van Bogaert
11:40 – 11:50 Recurrent “occult” 18F-FDG uptake in an atypical case of antineutrophil cytoplasmic antibody-associated vasculitis. A. Castiaux
11:50 – 12:00 Small, but brave. L. De Mey
12:00 – 12:10 Fever of unknown origin: the quest for the crown. A. Deleu
12:10 – 12:20 Case of insulinoma treated with PRRT. G. O. Wetshosele
12:20 – 12:30 Theragnostics: what you see, is what you treat. J. Gebruers
Oncology Update 14:00 – 14:45 Novel fluor-based PET tracers in oncology C. Deroose
14:45 – 15:30 Lung cancer and immunotherapy: How to read a PET-CT? N. Aide
Challenges in the reimbursement of rapid evolving technologies
(Ethics & Economy)
16:00 – 16:25 Nomenclature and revision of it: impact on nuclear medicine? B. Dehaes
16:25 – 16:50 From innovation to routine clinical use, a health technology assessment perspective. F. Hulstaert
16:50 – 17:30 Nuclear medicine within hospital networks: opportunities in the short and long terms M. van Uytven
17:30 – 17:45 General Discussion


11:00 – 11:30 New challenges and achievements in F18 radiochemistry G. Bormans
Radiopharmacy break-out session 11:30 – 12:00 Radiobiology for targeted radionuclide therapy J. Nonnekens
12:00 – 12:30 Difference between IMP an non-IMP clinical studies with radiopharmaceuticals S. De Lombaerde


11:00 – 11:30 The future of EARL R. Boellaard
break-out session
11:30 – 12:00 Standardization of absolute SPECT / CT quantization S.Peters
12:00 – 12:30 From the lab to the hospital – standards for radionuclide calibrators J. Paepen

Supported by

Industry satellite symposium

Presented by
GE Healthcare

12:30 – 13:00 One Birth, One Birthday

Virtual Poster Area

Poster Area
Keeping up appearances may cause harm: a breast-implant induced anaplastic large cell lymphoma appearing on [18F]FDG-PET/CT. S. Vermeulen
Evaluation of myocardial uptake of Radium-223 during Xofigo® radiopharmaceutical treatment in a patient with metastatic prostate cancer and cardiac amyloidosis: a case study. M. Manley
Soft-tissue sarcoma mimicking prostate cancer progression evidenced on 68Ga-PSMA-11 PET/CT Q. Ahmed Shagera
C(AVE)AT A. Geysen
Axillary lymph node activation induced by COVID-19 vaccination on FDG PET/CT in a patient with a history of aggressive relapsing lymphoma. P. Moyaert
Another differential diagnosis for lymphoma: Rosai-Dorfman syndrome G. Lens
COVID-19 Post-Vaccinal Lymphadenopathy Mimicking Lymph Node Metastases From Breast Neoplasia F. Fokoue
Suspicious thyroid cold nodule with intense focal 68Ga-DOTATATE uptake: a case report R. Manta
A perfect PMR pattern on FDG PET L. Boeckxstaens

Continuing education credits

The BELNUC ’21 Virtual symposium has been accredited with the following continuing education credits:


  • 03h00 for nuclear medicine physicians
  • 01h30 for physicists qualified in nuclear medicine
  • 02h00 for radiopharmacists


  • 4.5 CP (21002007; category 3; granted)
  • 2.0 CP (21002014; category 6; granted)

Federal Public Service: Health, Food Chain Safety, and Environment

  • Hospital pharmacists (modules 5; 8 points granted)

Please note that credits are only available when following the symposium live on the day of broadcast.

Young Nuclearist Challenge 2021

Back by popular demand: the Young Nuclearist Challenge 2021 will feature interesting case reports and you will help decide who wins the first prize of €300!